Identification of drugs that restore primary cilium expression in cancer cells
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
// Niamat Ali Khan 1 , Nicolas Willemarck 1 , Ali Talebi 1 , Arnaud Marchand 2 , Maria Mercedes Binda 1 , Jonas Dehairs 1 , Natalia Rueda-Rincon 1 , Veerle W. Daniels 1 , Muralidhararao Bagadi 1 , Deepak Balaji Thimiri Govinda Raj 3 , Frank Vanderhoydonc 1 , Sebastian Munck 4, 5 , Patrick Chaltin 2, 6 , Johannes V. Swinnen 1 1 KU Leuven - University of Leuven, Department of Oncology, Laboratory of Lipid Metabolism and Cancer, 3000 Leuven, Belgium 2 Cistim Leuven vzw, Bioincubator 2, 3001 Leuven, Belgium 3 European Molecular Biology Laboratory (EMBL), Grenoble Outstation and Unit of Virus Host-Cell Interactions (UVHCI), UJF-EMBL-CNRS, CS 90181, France 4 VIB Bio Imaging Core and Center for the Biology of Disease, 3000 Leuven, Belgium 5 KU Leuven - University of Leuven, Center for Human Genetics, 3000 Leuven, Belgium 6 Centre for Drug Design and Discovery (CD3) KU Leuven R & D, Bioincubator 2, 3001 Leuven, Belgium Correspondence to: Johannes V. Swinnen, e-mail: johan.swinnen@med.kuleuven.be Keywords: cilium, cancer, small molecules, therapeutics, high content analysis Received: July 12, 2015 Accepted: December 08, 2015 Published: February 04, 2016 ABSTRACT The development of cancer is often accompanied by a loss of the primary cilium, a microtubule-based cellular protrusion that functions as a cellular antenna and that puts a break on cell proliferation. Hence, restoration of the primary cilium in cancer cells may represent a novel promising approach to attenuate tumor growth. Using a high content analysis-based approach we screened a library of clinically evaluated compounds and marketed drugs for their ability to restore primary cilium expression in pancreatic ductal cancer cells. A diverse set of 118 compounds stimulating cilium expression was identified. These included glucocorticoids, fibrates and other nuclear receptor modulators, neurotransmitter regulators, ion channel modulators, tyrosine kinase inhibitors, DNA gyrase/topoisomerase inhibitors, antibacterial compounds, protein inhibitors, microtubule modulators, and COX inhibitors. Certain compounds also dramatically affected the length of the cilium. For a selection of compounds (Clofibrate, Gefitinib, Sirolimus, Imexon and Dexamethasone) their ability to restore ciliogenesis was confirmed in a panel of human cancer cell line models representing different cancer types (pancreas, lung, kidney, breast). Most compounds attenuated cell proliferation, at least in part through induction of the primary cilium, as demonstrated by cilium removal using chloral hydrate. These findings reveal that several commonly used drugs restore ciliogenesis in cancer cells, and warrant further investigation of their antineoplastic properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The primary cilium: a signalling centre during vertebrate development
Goetz, S. C., & Anderson, K. V. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2774 · Cited by 1,824 · cited 1×
“Tyrosine kinase inhibitors may enhance ciliogenesis by inhibiting ligand-dependent activation of cell-cycle entry or by regulating the coordination of signaling events linked to cilium-centrosome axis, that control cell cycle, differentiation and migration [39, 40].”
BackgroundWhen cilia go bad: cilia defects and ciliopathies
Fliegauf, M., Benzing, T., & Omran, H. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2278 · Cited by 1,257
HEF1-Dependent Aurora A Activation Induces Disassembly of the Primary Cilium
Pugacheva, E. N., Jablonski, S. A., Hartman, T. R., Henske, E. P., & Golemis, E. A. (2007) · Cell · doi:10.1016/j.cell.2007.04.035 · Cited by 890
Primary Cilia and the Cell Cycle
Plotnikova, O. V., Pugacheva, E. N., & Golemis, E. A. (2009) · Methods in Cell Biology · doi:10.1016/s0091-679x(08)94007-3 · Cited by 236
Primary cilia and coordination of receptor tyrosine kinase (RTK) signalling
Christensen, S. T., Clement, C. A., Satir, P., & Pedersen, L. B. (2012) · The Journal of Pathology · doi:10.1002/path.3004 · Cited by 181
Cited by
Karunakaran, K. B., Chaparala, S., Lo, C. W., & Ganapathiraju, M. K. (2020) · Scientific Reports · doi:10.1038/s41598-020-72024-4 · Cited by 56
Primary cilia influence progenitor function during cortical development
Zaidi, D., Chinnappa, K., & Francis, F. (2022) · Cells · doi:10.3390/cells11182895 · Cited by 19
Primary Cilia and Cardiovascular Risk Factors in Alzheimer's Disease
Sunderman, C. L., Forero, K. V., Alorjani, Q., Buqaileh, R., Gallagher, G. M., Ventresca, S. M., Messer, W. S., & AbouAlaiwi, W. A. (2025) · Brain Sciences · doi:10.3390/brainsci15091004 · Cited by 1
“A few studies have identified various compounds and drugs that restore cilia length, including MI-181 in retinal pigment epithelial-1 cells, cevimeline in Tg737 Orpk/Orpk cells, and Clofibrate, Sirolimus, and Dexamethasone in various cancer cell types [52,131,132].”
Metadata
- Authors
- Khan, N. A., Willemarck, N., Talebi, A., Marchand, A., Binda, M. M., Dehairs, J., Rueda-Rincon, N., Daniels, V. W., Bagadi, M., Raj, D. B. T. G., Vanderhoydonc, F., Munck, S., Chaltin, P., & Swinnen, J. V.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-02-04
- Volume
- 7
- Issue
- 9
- Pages
- 9975-9992
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2266000132
- Cited by
- 80
- References
- 5
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.